Status:
RECRUITING
Thebaine Urine Testing
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Urine Specimen Collection
Eligibility:
All Genders
18-65 years
Brief Summary
To develop and validate a urine drug screen to detect thebaine.
Eligibility Criteria
Inclusion
- Male or female
- Ages 18-65
- Healthy
Exclusion
- Allergy to poppy seeds, or any of the related food stuffs used in the study
- Celiac disease or gluten sensitivity
- Ongoing or opioid use in the past 6 months
- History of renal or hepatic disease or dysfunction
- Inability or unwillingness to give repeated urine specimens
- Unwillingness to refrain from eating poppy seed-containing products during the two-day course of the study
- Non-English speakers (due to study materials being in English)
- BMI greater than 30
- Antibiotic use in the previous 2 months
- Recent ingestion of poppy seeds from the previous 7 days
Key Trial Info
Start Date :
May 7 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07192887
Start Date
May 7 2025
End Date
March 1 2027
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229